Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
- 1 November 1988
- Vol. 9 (6), 1367-1372
- https://doi.org/10.1016/0196-9781(88)90204-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Effects of bombesin and insulin on inositol (1,4,5) trisphosphate and inositol (1,3,4) trisphosphate formation in Swiss 3T3 cellsCell, 1986
- Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH.The Journal of cell biology, 1986
- A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressinBiochemical Journal, 1985
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Activities and antagonism of bombesin on urinary smooth musclesEuropean Journal of Pharmacology, 1985
- Reduction of epidermal growth factor receptor affinity by heterologous ligands: Evidence for a mechanism involving the breakdown of phosphoinositides and the activation of protein kinase CBiochemical and Biophysical Research Communications, 1984
- A synthetic peptide that is a bombesin receptor antagonistNature, 1984
- Bombesin-like peptides and receptors in human tumor cell linesPeptides, 1983
- High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung CarcinomaScience, 1981